Performance Evaluation of the VIDAS TB-IGRA Assay.
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Amanda Lopes
Hopital Lariboisière
Principal Investigator - Charles Daley
National Jewish Health
Principal Investigator - Daniel Hoft
St. Louis University
Principal Investigator - David Pride
UC San Diego
Principal Investigator - Elisabeth Botelho-Nevers
North Hospital
Principal Investigator - Florence Doucet-Populaire
Antoine-Béclère Hospital
Principal Investigator - Frederic Méchaï
Avicenne Hospital
Principal Investigator - Maria Gennaro
Rutgers University
Principal Investigator - Michael Lauzardo
University of Florida
Principal Investigator - Nahed Ismail
University of Illinois at Chicago
Principal Investigator - Niaz Banaei
Stanford University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
24 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Universidade Federal de Mato Grosso Do Sul (ufms)
Campo Grande, Brazil
- Universidade Federal Da Grande Dourados (ufgd)
Dourados, Brazil
- Anti-Tb Center of Chambéry
Chambéry, France
- Lapeyronie Hospital
Montpellier, France
- Anti-Tb Center of Nanterre
Nanterre, France
- Avicenne Hospital
Paris, France
- Lariboisière Hospital
Paris, France
- North Hospital
Saint-Etienne, France
- National Center for Tuberculosis and Lung Disease
Tbilisi, Georgia
- Hinduja Hospital
Mumbai, India
- Inmi L. Spallanzani
Rome, Italy
- Autonomous University of Baja California
Mexicali, Mexico
- Task Applied Science, Delft Day Hospital Premises
Cape Town, South Africa
- University of Cape Town Centre for Lung Infection and Immunity
South Africa, South Africa
- Evelina London Children'S Hospital
London, United Kingdom
- Royal Free Hospital
London, United Kingdom
- St Thomas' Hospital
London, United Kingdom
- Stanford University
Palo Alto, California, United States
- Uc San Diego
San Diego, California, United States
- Naional Jewish Health
Denver, Colorado, United States
- University of Florida
Gainesville, Florida, United States
- University of Illinois- Chicago
Chicago, Illinois, United States
- Saint Louis University
St Louis, Missouri, United States
- Rutgers University
Newark, New Jersey, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 5 Dec 2019
- Primary completion
- 30 Jun 2021
- Completion
- 30 Jun 2021
- Last update posted
- 16 Jul 2021
- Registered enrollment
- 2,401
- Registry id
- NCT04048018
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.